
News|Articles|February 13, 2019
Aemcolo for Noninvasive Escheria coli Infection
Author(s)Drew Boxler
Advertisement
Aemcolo (rifamycin, Cosmo Pharmaceuticals)
Indications: treatment of travelers’ diarrhea caused by noninvasive strains of Escherichia coli in adults.
Dosage: Two 388mg tablets taken orally, twice daily for three days.
Contraindications: known hypersensitivity to rifamycin, any of the other rifamycin class antimicrobial agents (e.g. rifaximin), or any of the components in AEMCOLO
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Long-Term Adverse Effects After COVID-19 Vaccination Vary by Brand
2
Meta-Analysis Identifies 5 Risk Factors for Post-COVID-19 Condition
3
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
4
Investigational Oral AD109 Reduces Sleep Apnea Severity by 44%
5







































